IJCA-18543; No of Pages 3 International Journal of Cardiology xxx (2014) xxx–xxx Contents lists available at ScienceDirect International Journal of Cardiology journal homepage: www.elsevier.com/locate/ijcard Letter to the Editor Coronary angioscopy and optical coherence tomography for confirmation of drug-coated neointimal plaque after paclitaxelcoated balloon angioplasty for in-stent restenosis Kihei Yoneyama, Kohei Koyama, Yasuhiro Tanabe, Takanobu Mitarai, Ryo Kamijima, Shingo Kuwata, Hiroshi Yamazaki, Emi Nakano, Ken Kongoji, Tomoo Harada, Yoshihiro J. Akashi ⁎ Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan a r t i c l e i n f o Article history: Received 7 July 2014 Accepted 27 July 2014 Available online xxxx Keywords: Angioplasty Bare-metal stent Drug-coated balloon Drug-eluting balloon Neointima The paclitaxel drug-coated balloon (DCB) is an emerging device in percutaneous coronary intervention (PCI); it allows a rapid local release of an antirestenotic drug without the use of a durable polymer or metal scaffold [1]. The DCB has been proven to be effective with paclitaxel in preclinical trials and in clinical practice for the treatment of coronary lesions such as in-stent restenosis (ISR), de novo and bifurcation lesions, and those involving the peripheral arteries [2–4]. However, only a few reports on imaging of the drug covering the neointimal plaque at the ISR have been published. Here, we report confirmation of drug-coated neointimal plaque at the ISR lesion after paclitaxel DCB angioplasty with coronary angioscopy and optical coherence tomography (OCT). A 70-year-old man underwent a bare metal stent (Multi-link 8, 3.5 × 28 mm, Abbott Vascular, Santa Clara, CA, USA) implantation in the proximal left anterior descending artery (LAD) for acute myocardial infarction. Six-month follow-up coronary angiography demonstrated a critical ISR of the proximal LAD. The ISR was dilated using a conventional balloon (NC TENKU 3.25 × 15 mm, St Jude Medical Co, St. Paul, Minnesota, USA) with satisfactory final angiographic results (Fig. 1). OCT (C7XR system St Jude Medical Co, St. Paul, Minnesota, USA) revealed a severe neointimal plaque over the bare-metal stent (Fig. 2 and Movie 1). The ⁎ Corresponding author at: Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki-City, Kanagawa 216–8511, Japan. Tel.: +81 44 977 8111; fax: +81 44 976 7093. E-mail address: [email protected] (Y.J. Akashi). angioscope (Vecmova NEO, FiberTech, Tokyo, Japan) was manually pulled back from the distal to the proximal end with fluid infusion, and invisible stent struts with full neointimal coverage with white plaque mixed with minor hemorrhage after the conventional ballooning was confirmed. Subsequently, a DCB (Sequent Please 3.0 × 26 mm, B. Braun Melsungen, Berlin, Germany) was dilated at nominal pressure for 50 s at the ISR lesion. OCT demonstrated a successful drug covering of the neointimal plaque by the DCB (Fig. 2 and Movie 2). Additionally, angioscopy confirmed the drug-coated neointimal plaque at the ISR lesion (Fig. 3 and Movie 3). The patient was discharged on dual antiplatelet therapy (DAPT). DCB is highly effective in patients presenting with ISR. Its clinical application involves local drug delivery to the target vessel wall because otherwise the drug would be released into the blood before reaching the target lesion. Our findings support the DCB technique's usefulness in drug delivery on the neointimal plaque in human coronary lesions. To our knowledge, this is the first report of confirmation of drug-coated neointimal plaque at the ISR lesion by the paclitaxel-coated balloon using coronary angioscopy. Another concern would be whether the drug would get attached closely on the target vessel wall if it is a nonsmooth neointimal surface after conventional balloon angioplasty. In the present case, OCT revealed uncovered lesions due to a disruption of the neointimal surface after conventional balloon angioplasty. We do not know if the incomplete coverage detected by OCT imaging can be associated with further restenosis after DCB. Thus, additional imaging studies in patients with ISR are required to confirm the possibility of further developing a recurrent neointimal plaque at the incomplete covered segment after DCB. Despite no established protocol currently available for DAPT after DCB, we recommend treatment with DAPT after DCB to reduce cardiovascular events associated with acute and/ or late stent thrombosis secondary to the foreign substances detected on the surface of the target lesion by angioscopy and OCT imaging. These coronary imaging modalities can resolve this issue by identifying the optimal duration of DAPT after DCB with respect to pathology. Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.ijcard.2014.07.224. Sources of funding None. http://dx.doi.org/10.1016/j.ijcard.2014.07.224 0167-5273/© 2014 Elsevier Ireland Ltd. All rights reserved. Please cite this article as: Yoneyama K, et al, Coronary angioscopy and optical coherence tomography for confirmation of drug-coated neointimal plaque after paclitaxel-coated balloon angioplasty for in-stent restenosis, Int J Cardiol (2014), http://dx.doi.org/10.1016/j.ijcard.2014.07.224 2 K. Yoneyama et al. / International Journal of Cardiology xxx (2014) xxx–xxx Fig. 1. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon. (A) Coronary angiography showing in-stent (bare-metal stent) restenosis at the proximal left anterior descending artery. (B) Drug-coating balloon after balloon angioplasty. (C) Final angiography. Fig. 2. Optical coherence tomography images of coronary in-stent restenosis with a paclitaxel-coated balloon. (A1) After balloon angioplasty, OCT revealed a severe neointimal plaque within the bare-metal stent. (A2) Neointimal coverage with a large view. (B1) Successful covered neointimal plaque by a paclitaxel-coated balloon. (B2) There are thin high signals (white arrow) around the smooth surface. The shadows (*) are from the surface of the neointimal plaque. (B3) Spotty high signal (white arrow) with shadow indicating the granular drug covered area. (B4) Uncovered lesion at segmental level due to the disruption of the neointimal surface after balloon angioplasty. Conflict of interest None. References [2] Waksman R, Pakala R. Drug-eluting balloon: the comeback kid? Circ Cardiovasc Interv 2009;2:352–8. [3] Unverdorben M, Vallbracht C, Cremers B, et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 2009;119:2986–94. [4] Scheller B, Hehrlein C, Bocksch W, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. New Engl J Med 2006;355:2113–24. [1] Loh JP, Waksman R. Paclitaxel drug-coated balloons: a review of current status and emerging applications in native coronary artery de novo lesions. JACC Cardiovasc Interv 2012;5:1001–12. Please cite this article as: Yoneyama K, et al, Coronary angioscopy and optical coherence tomography for confirmation of drug-coated neointimal plaque after paclitaxel-coated balloon angioplasty for in-stent restenosis, Int J Cardiol (2014), http://dx.doi.org/10.1016/j.ijcard.2014.07.224 K. Yoneyama et al. / International Journal of Cardiology xxx (2014) xxx–xxx 3 Fig. 3. Angioscopy of coronary in-stent restenosis with a paclitaxel-coated balloon. (A) Invisible stent struts with full neointimal coverage with white plaque. (B) Appearance of hemorrhage in neointimal plaque after plain old balloon angioplasty (POBA). (C) Confirmation of the successful coverage of paclitaxel over the neointimal plaque. There were visible white granular materials on the covered neointimal plaque. Please cite this article as: Yoneyama K, et al, Coronary angioscopy and optical coherence tomography for confirmation of drug-coated neointimal plaque after paclitaxel-coated balloon angioplasty for in-stent restenosis, Int J Cardiol (2014), http://dx.doi.org/10.1016/j.ijcard.2014.07.224
© Copyright 2024 ExpyDoc